首页> 外文OA文献 >ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

【2h】

ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

机译：Alice：一种随机安慰剂对照期II研究，评估atezolizumab与转移三重阴性乳腺癌患者的免疫原性化疗相结合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
J. A. Kyte; A. Røssevold; R. S. Falk; B. Naume;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer [J] . J. A. Kyte, N. K. Andresen, H. G. Russnes, Journal of Translational Medicine . 2020,第1期

机译：图标：随机阶段IIB研究评估免疫原性化疗与Ipilimalab和Nivolumab联合转移激素受体阳性乳腺癌的患者
3. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial [J] . Schmid Peter, Rugo Hope S., Adams Sylvia, The lancet oncology . 2020,第1期

机译：Atezolizumab Plus Nab-Paclitaxel作为无可选择性，局部晚期或转移性三重阴性乳腺癌的一线治疗（Impassion130）：由随机，双盲，安慰剂控制，第3阶段试验的更新疗效结果
4. IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer [J] . Cortes Javier, Andre Fabrice, Goncalves Anthony, Future oncology . 2019,第17期

机译：IMPASSION132期III试验：早期复发转移性三重阴性乳腺癌的atezolizumab和化疗
5. Correlations between depressive symptoms and quality of life in metastatic breast cancer patients during chemotherapy [C] . Dragomir B.I., Campean A. European Association of Psychosomatic Medicine., Annual Meeting. . 2014

机译：化疗期间转移性乳腺癌患者抑郁症状与生活质量的相关性
6. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
7. ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer [O] . J. A. Kyte, A. Røssevold, R. S. Falk, 2020

机译：Alice：一种随机安慰剂对照期II研究评估atezolizumab与转移三重阴性乳腺癌患者的免疫原性化疗相结合
8. KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo for previously untreated, locally recurrent, inoperable or metastatic triple-negative breast cancer (mTNBC) [O] . J. Cortes Castan, Z. Guo, V. Karantza, 2017

机译：Keynote-355：随机，双盲，Pembrolizumab（Pembro）+化疗（Chemo）Vs安慰剂（PbO）+ Chemo用于先前未经处理的，局部复发性，不可操作或转移性三重阴性乳腺癌（MTNBC）

ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

著录项

相似文献

相关主题

期刊订阅